EBIT (Quarterly)

EBIT: Income before interest and taxes.

Haemonetics Corporation (HAE) had EBIT of $58.49M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$327.31M
Net Income	$38.68M
Cost of Goods Sold	$132.57M
Gross Profit	$194.74M
Operating Expenses	$268.82M
Operating Income	$58.49M
Non-Operating Income/Expense	$-7.21M
Pre-Tax Income	$51.28M
Normalized Pre-Tax Income	$51.28M
Income after Taxes	$38.68M
Income from Continuous Operations	$38.68M
Consolidated Net Income/Loss	$38.68M
Normalized Income after Taxes	$38.68M
EBIT	$58.49M
EBITDA	$88.80M
Weighted-Average Shares Outstanding (Basic)	47.59M
Weighted-Average Shares Outstanding (Diluted)	47.66M
Earnings per Share (EPS) (Basic)	$0.81
Earnings per Share (EPS) (Diluted)	$0.81
Balance Sheet Financials
Current Assets	$899.68M
Property, Plant, and Equipment	$292.48M
Long-Term Assets	$1.54B
Total Assets	$2.44B
Current Liabilities	$548.32M
Long-Term Debt	$920.39M
Long-Term Liabilities	$1.04B
Total Liabilities	$1.59B
Common Equity	$849.17M
Tangible Shareholders Equity	$-185.28M
Shareholders Equity	$849.17M
Common Shares Outstanding	46.75M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$128.72M
Cash Flow from Investing Activities	$-63.47M
Cash Flow from Financial Activities	$-78.99M
Beginning Cash	$306.76M
End Cash	$296.43M
Increase/Decrease in Cash	$-10.34M
Stock-Based Compensation	$16.90M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.64
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.52
Debt to Equity Ratio	1.44
Gross Margin	59.50%
Operating Margin	17.87%
EBIT Margin	17.87%
EBITDA Margin	--
Pre-Tax Profit Margin	15.67%
Profit Margin	11.82%
Free Cash Flow	$120.36M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.39
Receiveable Turnover	1.58
Days Sales in Receivables	56.94
Return on Equity	4.56%
Return on Tangible Equity	-20.88%
Return on Assets	1.58%
Return on Investments	2.19%
Book Value Per Share	$18.17
Free Cash Flow per Share	$2.53
Operating Cash Flow per Share	$2.70

Data from Zacks Investment Research, Inc.